Global Peptic Ulcer Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 17-May-2019
No. of pages: 115
Inquire Before Buying

Drug treatment of peptic ulcers is targeted at either counteracting aggressive factors or stimulating the mucosal defense.

Drugs that inhibit or neutralize gastric acid secretion include histamine H2-receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandins and antacids.

The global Peptic Ulcer Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Peptic Ulcer Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Peptic Ulcer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Peptic Ulcer Drugs in these regions.

This research report categorizes the global Peptic Ulcer Drugs market by top players/brands, region, type and end user. This report also studies the global Peptic Ulcer Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Daewoong Pharmaceutical

- Takeda Pharmaceutical

- Pfizer

- Abbott Laboratories

- AstraZeneca

- Cadila Healthcare

- Boehringer Ingelheim

- Eisai

- Yuhan

- GlaxoSmithKline Pharmaceuticals

Market size by Product

- by Product Type

- - Proton Pump Inhibitors

- - Potassium-Competitive Acid Blockers

- - Antacids

- - H2-Antagonists

- - Antibiotics

- - Ulcer Protective Drugs

- by Disease Indication

- - Gastritis

- - Gastric Ulcer

- - Duodenal Ulcer

- - Gastroesophageal Reflux Disease

Market size by End User

- Hospital Pharmacies

- Private Clinics

- Drug Stores

- Retail Pharmacies

- E-Commerce

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Peptic Ulcer Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Peptic Ulcer Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Peptic Ulcer Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Peptic Ulcer Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Peptic Ulcer Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Peptic Ulcer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Peptic Ulcer Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Peptic Ulcer Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Peptic Ulcer Drugs Market Size Growth Rate by Product
1.4.2 Proton Pump Inhibitors
1.4.3 Potassium-Competitive Acid Blockers
1.4.4 Antacids
1.4.5 H2-Antagonists
1.4.6 Antibiotics
1.4.7 Ulcer Protective Drugs
1.5 Market by End User
1.5.1 Global Peptic Ulcer Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Drug Stores
1.5.5 Retail Pharmacies
1.5.6 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peptic Ulcer Drugs Market Size
2.1.1 Global Peptic Ulcer Drugs Revenue 2014-2025
2.1.2 Global Peptic Ulcer Drugs Sales 2014-2025
2.2 Peptic Ulcer Drugs Growth Rate by Regions
2.2.1 Global Peptic Ulcer Drugs Sales by Regions
2.2.2 Global Peptic Ulcer Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Peptic Ulcer Drugs Sales by Manufacturers
3.1.1 Peptic Ulcer Drugs Sales by Manufacturers
3.1.2 Peptic Ulcer Drugs Sales Market Share by Manufacturers
3.1.3 Global Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Peptic Ulcer Drugs Revenue by Manufacturers
3.2.1 Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Peptic Ulcer Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Peptic Ulcer Drugs Price by Manufacturers
3.4 Peptic Ulcer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Peptic Ulcer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptic Ulcer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Peptic Ulcer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Peptic Ulcer Drugs Sales by Product
4.2 Global Peptic Ulcer Drugs Revenue by Product
4.3 Peptic Ulcer Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Peptic Ulcer Drugs Breakdown Data by End User
6 North America
6.1 North America Peptic Ulcer Drugs by Countries
6.1.1 North America Peptic Ulcer Drugs Sales by Countries
6.1.2 North America Peptic Ulcer Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Peptic Ulcer Drugs by Product
6.3 North America Peptic Ulcer Drugs by End User
7 Europe
7.1 Europe Peptic Ulcer Drugs by Countries
7.1.1 Europe Peptic Ulcer Drugs Sales by Countries
7.1.2 Europe Peptic Ulcer Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptic Ulcer Drugs by Product
7.3 Europe Peptic Ulcer Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Peptic Ulcer Drugs by Countries
8.1.1 Asia Pacific Peptic Ulcer Drugs Sales by Countries
8.1.2 Asia Pacific Peptic Ulcer Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Peptic Ulcer Drugs by Product
8.3 Asia Pacific Peptic Ulcer Drugs by End User
9 Central & South America
9.1 Central & South America Peptic Ulcer Drugs by Countries
9.1.1 Central & South America Peptic Ulcer Drugs Sales by Countries
9.1.2 Central & South America Peptic Ulcer Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Peptic Ulcer Drugs by Product
9.3 Central & South America Peptic Ulcer Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Peptic Ulcer Drugs by Countries
10.1.1 Middle East and Africa Peptic Ulcer Drugs Sales by Countries
10.1.2 Middle East and Africa Peptic Ulcer Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Peptic Ulcer Drugs by Product
10.3 Middle East and Africa Peptic Ulcer Drugs by End User
11 Company Profiles
11.1 Daewoong Pharmaceutical
11.1.1 Daewoong Pharmaceutical Company Details
11.1.2 Company Business Overview
11.1.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Daewoong Pharmaceutical Peptic Ulcer Drugs Products Offered
11.1.5 Daewoong Pharmaceutical Recent Development
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Company Business Overview
11.2.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Takeda Pharmaceutical Peptic Ulcer Drugs Products Offered
11.2.5 Takeda Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Peptic Ulcer Drugs Products Offered
11.3.5 Pfizer Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Laboratories Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Laboratories Peptic Ulcer Drugs Products Offered
11.4.5 Abbott Laboratories Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Peptic Ulcer Drugs Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Cadila Healthcare
11.6.1 Cadila Healthcare Company Details
11.6.2 Company Business Overview
11.6.3 Cadila Healthcare Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Cadila Healthcare Peptic Ulcer Drugs Products Offered
11.6.5 Cadila Healthcare Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Company Business Overview
11.7.3 Boehringer Ingelheim Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Boehringer Ingelheim Peptic Ulcer Drugs Products Offered
11.7.5 Boehringer Ingelheim Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Company Business Overview
11.8.3 Eisai Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Eisai Peptic Ulcer Drugs Products Offered
11.8.5 Eisai Recent Development
11.9 Yuhan
11.9.1 Yuhan Company Details
11.9.2 Company Business Overview
11.9.3 Yuhan Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Yuhan Peptic Ulcer Drugs Products Offered
11.9.5 Yuhan Recent Development
11.10 GlaxoSmithKline Pharmaceuticals
11.10.1 GlaxoSmithKline Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 GlaxoSmithKline Pharmaceuticals Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 GlaxoSmithKline Pharmaceuticals Peptic Ulcer Drugs Products Offered
11.10.5 GlaxoSmithKline Pharmaceuticals Recent Development
12 Future Forecast
12.1 Peptic Ulcer Drugs Market Forecast by Regions
12.1.1 Global Peptic Ulcer Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Peptic Ulcer Drugs Revenue Forecast by Regions 2019-2025
12.2 Peptic Ulcer Drugs Market Forecast by Product
12.2.1 Global Peptic Ulcer Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Peptic Ulcer Drugs Revenue Forecast by Product 2019-2025
12.3 Peptic Ulcer Drugs Market Forecast by End User
12.4 North America Peptic Ulcer Drugs Forecast
12.5 Europe Peptic Ulcer Drugs Forecast
12.6 Asia Pacific Peptic Ulcer Drugs Forecast
12.7 Central & South America Peptic Ulcer Drugs Forecast
12.8 Middle East and Africa Peptic Ulcer Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Peptic Ulcer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Peptic Ulcer Drugs Product Picture
Table Peptic Ulcer Drugs Market Segments
Table Key Manufacturers Peptic Ulcer Drugs Covered
Table Global Peptic Ulcer Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Peptic Ulcer Drugs Sales Market Share by Product 2014-2025
Figure Proton Pump Inhibitors Product Picture
Table Major Manufacturers of Proton Pump Inhibitors
Figure Potassium-Competitive Acid Blockers Product Picture
Table Major Manufacturers of Potassium-Competitive Acid Blockers
Figure Antacids Product Picture
Table Major Manufacturers of Antacids
Figure H2-Antagonists Product Picture
Table Major Manufacturers of H2-Antagonists
Figure Antibiotics Product Picture
Table Major Manufacturers of Antibiotics
Figure Ulcer Protective Drugs Product Picture
Table Major Manufacturers of Ulcer Protective Drugs
Table Global Peptic Ulcer Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Private Clinics
Figure Drug Stores
Figure Retail Pharmacies
Figure E-Commerce
Figure Peptic Ulcer Drugs Report Years Considered
Figure Global Peptic Ulcer Drugs Market Size 2014-2025 (Million US$)
Figure Global Peptic Ulcer Drugs Sales 2014-2025 (K Units)
Table Global Peptic Ulcer Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Peptic Ulcer Drugs Sales by Regions 2014-2019 (K Units)
Table Global Peptic Ulcer Drugs Sales Market Share by Regions 2014-2019
Figure Global Peptic Ulcer Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Peptic Ulcer Drugs Sales Market Share by Regions
Table Global Peptic Ulcer Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Peptic Ulcer Drugs Revenue Market Share by Regions 2014-2019
Figure Global Peptic Ulcer Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Peptic Ulcer Drugs Revenue Market Share by Regions
Table Global Peptic Ulcer Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Peptic Ulcer Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Peptic Ulcer Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Peptic Ulcer Drugs Revenue Share by Manufacturers (2014-2019)
Figure Peptic Ulcer Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Peptic Ulcer Drugs Price (2014-2019) (USD/Unit)
Table Peptic Ulcer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Peptic Ulcer Drugs Product Type
Table Date of International Manufacturers Enter into Peptic Ulcer Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Peptic Ulcer Drugs Sales by Product (2014-2019) (K Units)
Table Global Peptic Ulcer Drugs Sales Share by Product (2014-2019)
Figure Global Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure Global Peptic Ulcer Drugs Sales Market Share by Product in 2018
Table Global Peptic Ulcer Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Peptic Ulcer Drugs Revenue Share by Product (2014-2019)
Figure Global Peptic Ulcer Drugs Revenue Market Share by Product (2014-2019)
Figure Global Peptic Ulcer Drugs Revenue Market Share by Product in 2018
Table Peptic Ulcer Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Peptic Ulcer Drugs Sales by End User (2014-2019) (K Units)
Table Global Peptic Ulcer Drugs Sales Share by End User (2014-2019)
Figure Global Sales Peptic Ulcer Drugs Market Share by End User (2014-2019)
Figure Global Sales Peptic Ulcer Drugs Market Share by End User in 2018
Figure North America Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Peptic Ulcer Drugs Sales by Countries (2014-2019) (K Units)
Table North America Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Peptic Ulcer Drugs Sales Market Share by Countries
Table North America Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Peptic Ulcer Drugs Revenue Market Share by Countries
Figure United States Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Peptic Ulcer Drugs Sales by Product (2014-2019) (K Units)
Table North America Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Peptic Ulcer Drugs Market Share by Product
Table North America Peptic Ulcer Drugs Sales by End User (2014-2019) (K Units)
Table North America Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Peptic Ulcer Drugs Market Share by End User
Figure Europe Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Peptic Ulcer Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Peptic Ulcer Drugs Sales Market Share by Countries
Table Europe Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Peptic Ulcer Drugs Revenue Market Share by Countries
Figure Germany Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Peptic Ulcer Drugs Sales by Product (2014-2019) (K Units)
Table Europe Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Peptic Ulcer Drugs Market Share by Product
Table Europe Peptic Ulcer Drugs Sales by End User (2014-2019) (K Units)
Table Europe Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Peptic Ulcer Drugs Market Share by End User
Figure Asia Pacific Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Peptic Ulcer Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Peptic Ulcer Drugs Sales Market Share by Countries
Table Asia Pacific Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Peptic Ulcer Drugs Revenue Market Share by Countries
Figure China Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Peptic Ulcer Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Peptic Ulcer Drugs Market Share by Product
Table Asia Pacific Peptic Ulcer Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Peptic Ulcer Drugs Market Share by End User
Figure Central & South America Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Peptic Ulcer Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Peptic Ulcer Drugs Sales Market Share by Countries
Table Central & South America Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Peptic Ulcer Drugs Revenue Market Share by Countries
Figure Brazil Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Peptic Ulcer Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Peptic Ulcer Drugs Market Share by Product
Table Central & South America Peptic Ulcer Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Peptic Ulcer Drugs Market Share by End User
Figure Middle East and Africa Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Peptic Ulcer Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Countries
Table Middle East and Africa Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Peptic Ulcer Drugs Revenue Market Share by Countries
Figure GCC Countries Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Peptic Ulcer Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Peptic Ulcer Drugs Market Share by Product
Table Middle East and Africa Peptic Ulcer Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Peptic Ulcer Drugs Market Share by End User
Table Daewoong Pharmaceutical Company Details
Table Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daewoong Pharmaceutical Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Pfizer Company Details
Table Pfizer Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Cadila Healthcare Company Details
Table Cadila Healthcare Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cadila Healthcare Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Eisai Company Details
Table Eisai Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eisai Recent Development
Table Yuhan Company Details
Table Yuhan Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Yuhan Recent Development
Table GlaxoSmithKline Pharmaceuticals Company Details
Table GlaxoSmithKline Pharmaceuticals Peptic Ulcer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Pharmaceuticals Recent Development
Table Global Peptic Ulcer Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Peptic Ulcer Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Peptic Ulcer Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Peptic Ulcer Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Peptic Ulcer Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Peptic Ulcer Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Peptic Ulcer Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Peptic Ulcer Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Peptic Ulcer Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Peptic Ulcer Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Peptic Ulcer Drugs Value Chain
Table Peptic Ulcer Drugs Customers List
Table Peptic Ulcer Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs